Aids Malignancy Consortium
Clinical trials sponsored by Aids Malignancy Consortium, explained in plain language.
-
New hope for HIV patients: cheaper chemo may work just as well for kaposi sarcoma
Disease control Not yet recruitingThis study tests whether two different chemotherapy drugs, paclitaxel and pegylated liposomal doxorubicin, work equally well for treating Kaposi sarcoma in people living with HIV in sub-Saharan Africa. About 130 participants will receive one of the drugs every three weeks for six…
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Experimental drug shows promise for kaposi sarcoma lesions
Disease control Not yet recruitingThis study tests a drug called nirogacestat in 28 people with Kaposi sarcoma skin tumors. The drug blocks a protein that helps tumors grow, aiming to shrink lesions and stop them from spreading. While not a cure, it may offer a new way to control the disease in people who haven't…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Could a common heart drug shrink kaposi sarcoma tumors?
Disease control Not yet recruitingThis study tests whether propranolol, a drug typically used for high blood pressure, can treat Kaposi sarcoma. About 25 children and adults with measurable tumors will receive propranolol to see if tumors shrink or disappear. The goal is to find a safer, more accessible treatment…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC